baber/WOPTO huggingface dataset:
Patent JP-3681005-B2 (JP)
IPC: A61K47/48
Filed: 1995-11-09
Granted: 2005-08-10
Abstract: A membranous enzyme not yet described in the state-of-the-art can be extracted from cellular membrane fractions of blood leukocytes or monocytes/macrophages. Also disclosed is the use of substrates of this enzyme to prepare medicaments that contain these substrates as pharmaceutical active substance. These medicaments are useful to direct pharmacologically active substances to target cells and to enrich target cells with said substances. Also disclosed are in-vitro research systems containing this enzyme used to detect other substrates of this enzyme.
Patent JP-2709530-B2 (JP)
IPC: A61K31/44
Filed: 1993-12-10
Granted: 1998-02-04
Abstract: PCT No. PCT/US93/11792 Sec. 371 Date Jul. 21, 1995 Sec. 102(e) Date Jul. 21, 1995 PCT Filed Dec. 10, 1993 PCT Pub. No. WO94/18194 PCT Pub. Date Aug. 18, 1994Compounds of formula (I) where R1 is thienyl, phenyl or furyl, X and Y are halogen or hydrogen and Q is alkoxy or amino are useful as analgesic and antiinflamatory agents.    <IMAGE>  (I)
Patent JP-4498470-B2 (JP)
IPC: C21B13/00
Filed: 1997-11-05
Granted: 2010-07-07
Abstract: In a method of producing molten pig iron (9) or steel pre-products from lump ore which in at least one reduction zone is reduced to partially and/or completely reduced sponge iron (4) in a shaft furnace, the sponge iron (4) is melted down in a melt-down gasifying zone (8) of a melter gasifier (1) under supply of carbon-containing material (2) and oxygen and while simultaneously forming a reducing gas. To ensure that there will be a specific gap volume in the bed (13) of solid carbon carriers (2) even when charging fine-particle sponge iron (14) and hence that the bed (13) of solid carbon carriers (2) will be thoroughly flown through by gas, at least the sponge iron (4) is charged to the melt-down gasifying zone (8) discontinually, under formation of areas (14) of piled-up sponge iron which are embedded in the bed (13) of carbon carriers (2) and which are superposed and which are separated by solid carbon carriers (2), wherein each of the areas (14) of piled-up sponge iron while sparing a cross section zone (15) of the melt-down gasifying zone (8) extends over the cross section of the same and wherein the reducing gas forming the melt-down gasifying zone (8) flows past the areas (14) of piled-up sponge iron under melting of the same and upwards through the cross section zones (15) that are free from sponge iron and formed from carbon carriers (2), and flows through these zones.
Patent JP-4239114-B2 (JP)
IPC: A61K35/16
Filed: 1996-11-26
Granted: 2009-03-18
Abstract: Systems and methods treat plasma carrying contaminants and leukocytes that are capable of entraining contaminants. The systems and methods separate leukocytes from the plasma by filtration, thereby removing contaminants entrained within leukocytes. The systems and methods also add to the plasma a photoactive material and emit radiation at a selected wavelength into the plasma to activate the photoactive material and thereby eradicate the contaminant that is free of entrainment by leukocytes.
Patent JP-4101880-B2 (JP)
IPC: F16D41/08
Filed: 1997-01-23
Granted: 2008-06-18
Abstract: A force transfer device 30 includes an inner race 40 and an outer race 38 and a plurality of reversible wedging elements 34 located between the inner and outer races. This device 30 allows for continuous force transfer between the inner and outer race. This device 30 further allows for locking the inner race 40 relative to the outer race 38 in infinitely varying positions. The device 30 includes scallops on at least one race which scallops are of complex shape in order to manage wedging of the wedging elements and surface stresses between the wedging elements and the race contact surfaces. The device 30 is also reversible.
Patent JP-4312259-B2 (JP)
IPC: C12N15/09
Filed: 1996-04-29
Granted: 2009-08-12
Abstract: Fully human antibodies against a specific antigen can be prepared by administering the antigen to a transgenic animal which has been modified to produce such antibodies in response to antigenic challenge, but whose endogenous loci have been disabled. Various subsequent manipulations can be performed to obtain either antibodies per se or analogs thereof.
Patent JP-4531867-B2 (JP)
IPC: C07H19/207
Filed: 1998-02-06
Granted: 2010-08-25
Abstract: The present invention relates to certain novel dinucleotides and formulations thereof which are highly selective agonists of the P2Y<SUB>2 </SUB>and/or P2Y<SUB>4 </SUB>purinergic receptor. They are useful in the treatment of chronic obstructive pulmonary diseases such as chronic bronchitis, PCD, cystic fibrosis, as well as prevention of pneumonia due to immobility. Furthermore, because of their general ability to clear retained mucus secretions and stimulate ciliary beat frequency, the compounds of the present invention are also useful in the treatment of sinusitis, otitis media and nasolacrimal duct obstruction. They are also useful for treatment of dry eye disease and retinal detachment as well as facilitating sputum induction and expectoration.
Patent JP-4563516-B2 (JP)
IPC: A61K9/00
Filed: 1998-02-20
Granted: 2010-10-13
Abstract: A rapidly dispersing dosage form is described. The dosage form releases its active ingredients within a period of less than about ninety seconds. These dosage forms exhibit a three-dimensional shape that is retained for adequate storage but is readily dispersed in the presence of excess moisture. Also disclosed are methods of administration of a medicament and a process for the preparation of rapidly dispersing dosage forms.
Patent PL-162354-B2 (PL)
Title: Portable injection device
Inventor: PAWLOWSKI JANUSZ
Filed: 1990-11-15
Abstract: 1. Portable shower device for taking shower equipped with a water container, shower hose and shower head, and a stand characterised in that it is equipped with a cubicle (1) in the form of a sack made of non-transparent and elastic foil with a vertical cut (2) which ends above the base of the cubicle (1), and the cubicle (1), below the cut (2), forms a used-up water container (3), and the whole cubicle (1) constitutes a cover and is hang on a hoop (6) combined with a stand (7), and the water container (9) is hang on a rope (12) going through a block mechanism (13) which is located on a console (8) connected to the stand (7).<IMAGE>
Patent ES-2374382-B2 (ES)
Title: Stent.
Inventor: GALLASTEGUI GOIBURU JAVIER
IPC: A61F2/90
Filed: 2011-10-27
Granted: 2012-12-05
Abstract: Stent.#Comprende en principio una estructura tubular conformada por una pared envolvente definida por una armadura de malla pudiendo adoptar una posición plegada para introducirse dentro de un conducto tubular y una segunda posición desplegada para instalarse dentro de tal conducto tubular.#Se caracteriza porque:#- la estructura tubular comprende una configuración tronco-cónica al menos en la posición desplegada;#- la estructura tubular integra unos tramos longitudinales (3) correspondientes con las generatrices de la citada configuración tronco-cónica, y al menos dos anillos (4) de trayectoria circunferencial de diferente diámetro unidos a los tramos longitudinales (3);#- los anillos (4) de trayectoria circunferencial integran en la posición plegada, unos dobleces (6) contenidos en la superficie envolvente de la estructura tubular (1).
Patent ES-2482567-B2 (ES)
Title: Conjunto de rodamiento con casquillo de seguridad y procedimiento de inserción
Inventor: SALVADOR LOU JAVIER
IPC: F16C41/04
Filed: 2012-06-20
Granted: 2015-04-30
Abstract: Conjunto de rodamiento con casquillo de seguridad y procedimiento de inserción, del tipo de los constituidos por dos unidades pre-montadas de rodamiento de rodillos cónicos, reemplazables en el buje de rueda de vehículos comerciales, que comprenden en cada caso un aro exterior y un aro interior, incorporando entre los mismos una pluralidad de rodillos cónicos en una jaula y una caja identificativa que fija el aro exterior caracterizado por incorporar un casquillo de seguridad de dimensiones equivalentes a las dimensiones de la unidad pre-montada, intercalado entre el aro exterior y aro interior, creando un conjunto compacto, que sirve como utillaje para el montaje de las unidades pre-montadas en el buje y como utillaje para el montaje de los retenes en una cavidad conformada entre el aro interior y el buje, incorporando además en una de las unidades pre-montadas un cierre de estanqueidad mediante un procedimiento realizado en cuatro fases.
Patent ES-2599603-B2 (ES)
Title: Microdieta para paralarvas de pulpo común Octopus vulgaris (Cuvier, 1797)
Inventor: ESTEFANELL UCHA JUAN A
IPC: A23K50/80
Filed: 2015-07-28
Granted: 2018-05-14
Abstract: La presente invención se refiere a una microdieta para alimentar paralarvas de pulpo común con la finalidad de obtener juveniles bentónicos. La microdieta incluye diferentes componentes: harina de calamar liofilizada, yema de huevo en polvo, aceites de origen marino y una mezcla de micro-elementos (Fe, Mg, Cu y S). La microdieta presenta un tamaño de partícula de 250  1000 {mi} y fue suministrada a partir de día 30-40 de cultivo en 3  18 tomas / diarias. La microdieta fue aceptada e ingerida por las paralarvas, induciendo un crecimiento positivo hasta los 73 días de edad.
Patent AU-2002342405-B2 (AU)
Title: Split phase fuel conditioner
Inventor: LAMPARD ROBERT DOUGLAS
IPC: F02B19/16
Filed: 2002-11-25
Granted: 2010-04-29
Abstract: A split phase fuel conditioner 10 includes a main body 20 defining an ignition chamber 22 . A transfer passage 24 is in fluid communication between the ignition chamber 22 and chamber 14 . A valve 28 selectively opens and closes a throat 26 of the transfer passage 24 to control fluid communication between chamber 22 and chamber 14 . A first injector 30 injects a first fuel volume into ignition chamber 22 . A second fuel injector 32 injects a second volume of fuel directly into transfer passage 24 through the first valve 28 . The first fuel volume is ignited in the chamber 22 to form an ignition plasma. Valve 28 is opened allowing the ignition plasma to condition the second fuel volume by vaporising the second fuel volume. The ignition plasma then sweeps the conditioned second fuel volume into the combustion chamber where it combusts in a controlled manner.
Patent AU-2003244031-B2 (AU)
Title: Humeral shoulder prosthesis
Inventor: ONDRLA JEFFREY M
IPC: A61B17/58
Filed: 2003-09-01
Granted: 2009-05-07
Abstract: The humeral portion of a shoulder prosthesis includes a diaphyseal component (10) configured for fixation within the humerus, a metaphyseal component (30), configured for removable implantation within the metaphysis of the humerus, and an engagement mechanism for removably engaging the two components. The metaphyseal component (30) can initially include a convex articulating surface that can be replaced with a concave surface during the shoulder arthroplasty procedure or in a subsequent revision surgery. The metaphyseal component (30) can also include a feature to facilitate removal of the component from the bone once it has been disengaged from the diaphyseal component (10). <IMAGE>
Patent AU-2003270272-B2 (AU)
Title: Depigmenting composition for the skin comprising adapalene and at least one depigmenting agent
Inventor: PELISSON ISABELLE
IPC: A61K31/19
Filed: 2003-09-01
Granted: 2008-06-19
Abstract: Topically applicable skin depigmenting compositions, suited for treatment of such hyperpigmentary disorders as melasma and chloasma, contain a thus effective amount of at least one skin depigmenting active agent, for example hydroquinone or 4-hydroxyanisole, in admixture with a depigmentation-accelerating amount of adapalene (6-[3-(1-adamantyl)-4-methoxyphenyl]-2-napthanoic acid), and optionally with at least one sunscreen, formulated into a topically applicable, physiologically acceptable medium therefor.
Patent AU-2003270348-B2 (AU)
Title: Compositions and methods for the diagnosis and treatment of tumor
Inventor: DAVIS DAVID P
IPC: G01N33/574
Filed: 2003-09-05
Granted: 2010-08-26
Abstract: The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
Patent AU-2004237227-B2 (AU)
Title: Apparatus and method for processing service interactions
Inventor: ERIC CLORAN MICHAEL
IPC: G06N5/00
Filed: 2004-05-05
Granted: 2011-07-14
Abstract: An interactive voice and data response system then directs input to a voice, text, and web-capable software-based router, which is able to intelligently respond to the input by drawing on a combination of human agents, advanced speech recognition and expert systems, connected to the router via a TCP/IP network. The digitized input is broken down into components so that the customer interaction is managed as a series of small tasks rather than one ongoing conversation. The router manages the interactions and keeps pace with a real-time conversation. The system utilizes both speech recognition and human intelligence for purposes of interpreting customer utterance or customer text. The system may use more than one human agent, or both human agents and speech recognition software, to interpret simultaneously the same component for error-checking and interpretation accuracy.
Patent AU-2004263221-B2 (AU)
Title: Process for preparing maltitol enriched products
Inventor: STOUFFS ROBERT HENRI-MARCEL
IPC: A23L27/30
Filed: 2004-07-06
Granted: 2008-06-26
Abstract: The current invention relates to a process for preparing maltitol enriched products and said process is chromatographically fractionating a maltose syrup followed by hydrogenating it into a liquid maltitol enriched product and optionally solidification or crystallization of maltitol. Liquid, solid and crystalline maltitol of different purities are obtainable by a single process.
Patent AU-2004318974-B2 (AU)
Title: Device for dynamic bone stabilization
Inventor: HESS MARTIN
IPC: A61B17/70
Filed: 2004-04-28
Granted: 2010-04-08
Abstract: A device for the dynamic stabilization of bones or bone fragments, especially vertebral bodies, includes a longitudinal carrier having a longitudinal axis and at least two bone anchoring devices. Each bone anchoring device has an anchoring part that attaches to bone and a connecting part that detachably fastens the longitudinal carrier to the anchoring device. The longitudinal carrier has in the axial direction a number of n flexible segments where n>=1. Each flexible segment has a cross-sectional surface orthogonal to the longitudinal axis that corresponds neither to a circle nor to a regular polygon. The longitudinal carrier also has a number of m essentially stiff segments where m=(n+1). The total number of flexible and stiff axial segments is >=(2n+1).
Patent AU-2005231675-B2 (AU)
Title: An improved roller for selectively applying paint at surface corners
Inventor: ERH POH SOON
IPC: B05C17/02
Filed: 2005-03-22
Granted: 2010-09-16
Abstract: A frustoconically-shaped paint roller (210) to selectively apply paint to surfaces and surface corners. The paint roller has a rolling guide (280) that permits the roller to rotate eccentrically so as to accommodate rough or uneven surfaces. A circular integral guard (260) of predetermined diameter is present to prevent the user from applying excessive force when using the roller and squeezing paint from the roller. When used correctly, the integral guard does not contact the surface to be painted. One embodiment of the invention has a chamber (270) to store paint so that the repeated frequent charging of the roller with paint from a can or tray is avoided.
Patent AU-2005256395-B2 (AU)
Title: MAO-B inhibitors
Inventor: WYLER RENE
IPC: C07C255/54
Filed: 2005-06-15
Granted: 2010-08-12
Abstract: The invention relates to compounds of the formula and their pharmaceutically acceptable salts wherein R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4</SUP>, R<SUP>5</SUP>, n, m, and o are as defined in the specification. The compounds are selective monoamine oxidase beta inhibitors and are useful for the treatment and prevention of Alzheimer's disease and senile dementia, as well as other CNS disorders. The invention also relates to processes for preparing such compounds and pharmaceutical compositions containing them.
Patent AU-2005269261-B2 (AU)
Title: Submarine water reservoir
Inventor: TANGNEY PETER JOHN
IPC: E03F1/00
Filed: 2005-08-02
Granted: 2012-01-19
Abstract: A method of storing water comprising restraining at least one flexible storage reservoir (12) in a submerged position within a body of salt water (14); establishing a terrestrial intake (16) in fluid communication with the flexible storage reservoir (12) and establishing a terrestrial outlet (30) in fluid communication with the flexible storage reservoir for the release of stored water.
Patent AU-2005274927-B2 (AU)
Title: Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
Inventor: GUZZO PETER R
IPC: A61K31/47
Filed: 2005-07-15
Granted: 2011-11-03
Abstract: The compounds of the present invention are represented by the chemical structure found in Formula (I): wherein: the carbon atom designated * is in the R or S configuration; and X is a fused bicyclic carbocycle or heterocycle selected from the group consisting of benzofuranyl, benzo[]thiophenyl, benzoisothiazolyl, benzoisoxazolyl, indazoly'1, indolyl, isoindolyl, indolizinyl, benzoimidazolyl, benzooxazolyl, benzothiazolyl, benzotriazolyl, imidazo[1,2-]pyridinyl, pyrazolo[1,5-]pyridinyl, [1,2,4]triazolo[4,]pyridinyl, thieno[2,3-]pyridinyl, thieno[3,2-]pyridinyl, 1-pyrrolo[2,]pyridinyl, indenyl, indanyl, dihydrobenzocycloheptenyl, tetrahydrobenzocycloheptenyl, dihydrobenzothiophenyl, dihydrobenzofuranyl, indolinyl, naphthyl, tetrahydronaphthyl, quinolinyl, isoquinolinyl, 4-quinolizinyl, 9-quinolizinyl, quinazolinyl, cinnolinyl, phthalazinyl, quinoxalinyl, benzo[1,2,3]triazinyl, benzo[1,2,4]triazinyl, 2-chromenyl, 4-chromenyl, and a fused bicyclic carbocycle or fused bicyclic heterocycle optionally substituted with substituents (1 to 4 in number) as defined in R; with R, R, R, R, R, R, R, R, and R defined herein.
Patent AU-2005338370-B2 (AU)
Title: Multipotent stem cells derived from human adipose tissue and cellular therapeutic agents comprising the same
Inventor: KANG KYUNG SUN
IPC: A61K35/12
Filed: 2005-12-20
Granted: 2011-06-09
Abstract: Human adipose tissue-derived multipotent adult stem cells are provided, which are characterized by the ability to be maintained in an undifferentiated state for a long period of time by forming spheres and which have high proliferation rates. Also provided are methods for isolating and maintaining the adult stem cells, and methods for differentiating the multipotent adult stem cells into nerve cells, fat cells, cartilage cells, osteogenic cells, muscle cells, endothelial cells, hepatic cells and insulin-releasing pancreatic β-cells. Also provided are cellular therapeutic agents for treating osteoarthritis, osteoporosis, nerve disease, diabetes and for forming breast tissue, which contain differentiated cells or the adult stem cells.
Patent AU-2006202948-B2 (AU)
Title: Multiphase fluid characterization
Inventor: BENTLEY SCOTT N
IPC: C10G33/08
Filed: 2006-07-11
Granted: 2007-09-13
Abstract: Methods for determining and validating a first phase fraction of a gravitationally-separated multiphase fluid by conducting physical and electrical property measurements on samples of the fluid. The water content of crude petroleum oil is determined after the oil and water have begun to separate into phase layers such as occurs during un-agitated holding of the crude petroleum oil. A series of measurements of electrical properties such as permittivity and physical properties such as density is collected. The density minima can be used to generate hindsight determinations of average properties, such as the dry oil phase density, which in turn can be used to increase the accuracy of the water percentage in the oil determined by the permittivity and density methods. Flow weighted averages of water percentages by each method can be used to determine and validate the water content of the crude petroleum oil.
Patent AU-2006244748-B2 (AU)
Title: An insect trap and a method of attracting insects
Inventor: JOHN CHILD KENNETH
IPC: A01M1/08
Filed: 2006-02-10
Granted: 2011-11-24
Abstract: An insect trap (100) is disclosed which has insect retention means (300) for preventing escape of insects which enter an effective zone of said insect retention means (300) and insect attractant means (200) for attracting insects from a selected group of insects to within said effective zone of said insect retention means (300). The attractant means include at least one variable infra-red radiation emission means (2, 4) adapted to emit variable infra-red radiation. The arrangement is such that insects from the selected group which are outside the trap (100) can detect the variable infra-red radiation and are attracted to an area within the effective zone of the insect retention means (300). A method of attracting insects from a selected group of insects to a predetermined location is also disclosed.
Patent AU-2006265997-B2 (AU)
Title: Histamine H3 receptor agents, preparation and therapeutic uses
Inventor: RICHARD FINLEY DON
IPC: C07D207/09
Filed: 2006-06-28
Granted: 2011-11-17
Abstract: The present invention discloses novel compounds of Formula I or pharmaceutically acceptable salts thereof which have histamine-H3 receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I as well as methods of using them to treat obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases. (Formula I)
Patent AU-2006268683-B2 (AU)
Title: Method and device for controlling access to encrypted data
Inventor: KUDELSKI HENRI
IPC: H04N5/00
Filed: 2006-07-06
Granted: 2010-07-22
Abstract: The method involves receiving a pair of control messages (ECM1, ECM2), where each control message comprises a control word and temporary stamp. A duration corresponding to the difference between the stamps of the control messages is determined. An error counter (CE) is incremented if the duration is less than a predefined duration. The counter is decremented if the duration is greater than or equal to the predefined duration. An independent claim is also included for a device for controlling access to encrypted data.
Patent AU-2006281607-B2 (AU)
Title: Isolation of the t-complex distorters and applications thereof
Inventor: HERRMANN BERNHARD
IPC: C12N15/85
Filed: 2006-08-11
Granted: 2012-04-26
Abstract: The present invention relates to a method for producing a transgenic non human male animal, preferably a mammal, fish, bird or insect, wherein the transgene(s) confer(s) a change in the transmission ratio of (a) genetic trait(s) to the offspring of said non human male animal, preferably mammal, fish, bird or insect to a non-Mendelian ratio, said method comprising introducing (a) a first nucleic acid molecule encoding an expression product with a Responder function into a chromosome of a non-human germ cell, (fertilized) egg cell, embryonic cell or a cell derived therefrom, of the same species as the transgenic male to be prepared, said chromosome containing or conferring said genetic trait(s), thereby linking on said chromosome said Responder function to the genetic trait(s); and (b) at least one second nucleic acid molecule encoding an expression product with a Distorter function into (a) chromosome(s) of a non-human germ cell, (fertilized) egg cell, embryonic cell or a cell derived therefrom, of the same species as the transgenic male to be prepared, wherein said expression product with a Distorter function is a factor involved in G protein signaling, wherein said first nucleic acid molecule encoding an expression product with Responder function and said at least one second nucleic acid molecule encoding an expression product with a Distorter function are introduced into the same or different chromosomes.